AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
-12.54%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$1.8B
AUM Growth
+$1.8B
Cap. Flow
-$127M
Cap. Flow %
-7.06%
Top 10 Hldgs %
51.01%
Holding
142
New
4
Increased
8
Reduced
8
Closed
7

Top Buys

1
SRRK icon
Scholar Rock
SRRK
$34.6M
2
FATE icon
Fate Therapeutics
FATE
$14.9M
3
CYTK icon
Cytokinetics
CYTK
$10.8M
4
WVE icon
Wave Life Sciences
WVE
$6.5M
5
CINC
CinCor Pharma, Inc. Common Stock
CINC
$2.58M

Top Sells

1
ARGX icon
argenx
ARGX
$71M
2
SGEN
Seagen Inc. Common Stock
SGEN
$22.1M
3
PTGX icon
Protagonist Therapeutics
PTGX
$18.9M
4
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$16.8M
5
BLU
BELLUS Health Inc.
BLU
$13.9M

Sector Composition

1 Healthcare 93.1%
2 Consumer Discretionary 5.5%
3 Financials 0.65%
4 Consumer Staples 0.29%
5 Industrials 0.16%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ACHL
51
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
$5.68M 0.3% 2,255,375 – –
KRON
52
DELISTED
Kronos Bio
KRON
$5.62M 0.3% 1,542,954 – –
DSGN icon
53
Design Therapeutics
DSGN
$315M
$5.6M 0.3% 400,000 – –
OVID icon
54
Ovid Therapeutics
OVID
$91M
$5.38M 0.29% 2,500,000 – –
OTLY
55
Oatly Group
OTLY
$533M
$5.19M 0.28% 1,500,000 – –
SQZ
56
DELISTED
SQZ Biotechnologies Company
SQZ
$5.11M 0.27% 1,606,309 – –
ALPN
57
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$5.05M 0.27% 593,030 – –
MRNS
58
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$4.84M 0.26% 1,000,000 – –
CFRX
59
DELISTED
ContraFect Corporation
CFRX
$4.61M 0.25% 1,500,000 – –
LPTX icon
60
Leap Therapeutics
LPTX
$12M
$4.6M 0.25% 4,000,000 – –
LYEL icon
61
Lyell Immunopharma
LYEL
$213M
$4.56M 0.24% 700,000 – –
BDTX icon
62
Black Diamond Therapeutics
BDTX
$157M
$4.05M 0.22% 1,646,517 – –
ALXO icon
63
ALX Oncology
ALXO
$62.7M
$4.05M 0.22% 500,000 – –
TSHA icon
64
Taysha Gene Therapies
TSHA
$797M
$3.87M 0.21% 1,040,882 – –
SYRS
65
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$3.85M 0.21% 4,000,000 +500,000 +14% +$481K
SE icon
66
Sea Limited
SE
$110B
$3.84M 0.21% 57,500 – –
NBTX
67
Nanobiotix
NBTX
$429M
$3.8M 0.2% 1,000,000 – –
PFTA
68
DELISTED
Perception Capital Corp. III Class A Ordinary Share
PFTA
$3.71M 0.2% 380,000 – –
RXRX icon
69
Recursion Pharmaceuticals
RXRX
$2.04B
$3.66M 0.2% 450,000 – –
RNA icon
70
Avidity Biosciences
RNA
$5.99B
$3.63M 0.19% 250,000 – –
ACIU icon
71
AC Immune
ACIU
$205M
$3.61M 0.19% 1,000,000 – –
DYN icon
72
Dyne Therapeutics
DYN
$1.92B
$3.61M 0.19% 525,000 – –
ADVM icon
73
Adverum Biotechnologies
ADVM
$64.6M
$3.6M 0.19% 3,000,000 – –
APTX
74
DELISTED
Aptinyx Inc. Common Stock
APTX
$3.41M 0.18% 6,116,493 – –
STOK icon
75
Stoke Therapeutics
STOK
$1.08B
$3.3M 0.18% 250,000 – –
1 2
3
4 5